Immune Regulation News Volume 14.18 | May 20 2022

    0
    96







    2022-05-20 | IRN 14.18


    Immune Regulation News by STEMCELL Technologies
    Vol. 14.18 – 20 May, 2022
    TOP STORY

    Activation of the Transcription Factor NRF2 Mediates the Anti-Inflammatory Properties of a Subset of Over-the-Counter and Prescription NSAIDs

    Using genetic and pharmacologic approaches, the authors found that nonsteroidal anti-inflammatory drug (NSAID)-mediated GDF15 induction was dependent on the activation of nuclear factor erythroid 2-related factor 2 (NRF2) in myeloid cells.
    [Immunity]

    AbstractGraphical Abstract

    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    Zbtb20 Identifies and Controls a Thymus-Derived Population of Regulatory T Cells That Play a Role in Intestinal Homeostasis

    Zbtb20 expression identified and controlled the function of a distinct subset of Tregs that were involved in intestinal homeostasis.
    [Science Immunology]

    AbstractPress Release

    The Phosphatase PTEN Links Platelets with Immune Regulatory Functions of Mouse T Follicular Helper Cells

    Investigators showed that mice with platelet-specific deletion of phosphatase and tensin homolog (Pten) developed age-related lymphoproliferative diseases and humoral autoimmunity not seen in wildtype animals.
    [Nature Communications]

    Full Article

    The Ubiquitin Ligase Cul5 Regulates CD4+ T Cell Fate Choice and Allergic Inflammation

    Researchers showed that the E3 ubiquitin ligase Cul5 determined fate selection in CD4+ T cells by regulating IL-4 receptor signaling.
    [Nature Communications]

    Full Article

    ATP Spreads Inflammation to Other Limbs through Crosstalk between Sensory Neurons and Interneurons

    The authors showed that ATP served as both a neurotransmitter and an inflammation enhancer, thus acting as an intermediary between the local inflammation and neural pathway that induced inflammation on the other side.
    [Journal of Experimental Medicine]

    AbstractPress Release

    Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells

    Scientists used mice deficient in tight-junction protein Claudin-12 (Cldn12) compared to wild-type mice and found that loss of host Cldn12 inhibited the growth of transplanted tumors, reduced intratumoral accumulation of myeloid-derived suppressor cells, increased anti-tumor immune responses, and decreased tumor vescular density.
    [Cancer Research]

    Abstract

    Insights into Immune Escape during Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer

    Investigators showed that Nitroso-N-methylurea–induced mammary tumors in outbred Sprague-Dawley rats recapitulated the heterogeneity for mutational profiles, ER expression, and immune evasive mechanisms observed in human breast cancer.
    [Cancer Immunology Research]

    Full Article

    Retinoic Acid Signaling Acts as a Rheostat to Balance Treg Function

    Researchers employed mouse models in which retinoic acid (RA) signaling was silenced by the expression of the dominant negative receptor RARα in all T cells.
    [Cellular & Molecular Immunology]

    Abstract

    WEE1 Inhibition Enhances the Antitumor Immune Response to PD-L1 Blockade by the Concomitant Activation of STING and STAT1 Pathways in SCLC

    The authors demonstrated cell-autonomous and immune-stimulating activity of WEE1 inhibition in small cell lung cancer (SCLC) models.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Myeloid Cell-Specific Topoisomerase 1 Inhibition Using DNA Origami Mitigates Neuroinflammation

    Investigators showed that topoisomerase 1 (TOP1) was highly expressed in neuroinflammatory conditions, and TOP1 inhibition using camptothecin and its FDA-approved analog topotecan reduced inflammatory responses in microglia/macrophages and ameliorated neuroinflammation in vivo.
    [EMBO Reports]

    Full ArticleGraphical Abstract

    Recruitment of Monocytes Primed to Express Heme Oxygenase-1 Ameliorates Pathological Lung Inflammation in Cystic Fibrosis

    Scientists revealed the mechanism of action of PP-007 responsible for the immunomodulatory function observed in clinical trials for a wide range of diseases and demonstrated the potential use of PP-007 in controlling neutrophilic pulmonary inflammation by promoting the expression of HO-1 in monocytes/macrophages.
    [Experimental & Molecular Medicine]

    Full Article

    Variants of Beta-Glucan Polysaccharides Downregulate Autoimmune Inflammation

    Researchers investigated the effects of β-glucan polysaccharides in the effector phase of arthritis and as regulators of psoriasis and psoriatic arthritis-like symptoms in mice.
    [Communications Biology]

    Full Article

    Peripheral NOD-Like Receptor Deficient Inflammatory Macrophages Trigger Neutrophil Infiltration into the Brain Disrupting Daytime Locomotion

    Scientists investigated whether inappropriate macrophage-evoked inflammation altered central nervous system control of daily-life animal locomotion using a set of zebrafish mutants selected for specific macrophage dysfunction and microglia deficiency.
    [Communications Biology]

    Full Article


    Learn about immunological considerations for hPSC banking by watching Dr. David Turner's webinar from the Nature Research Round Table on hPSC Quality
    REVIEWS

    Immunosuppressive Cells in Cancer: Mechanisms and Potential Therapeutic Targets

    The authors summarize the phenotype, function, and potential therapeutic targets of immunosuppressive cells in the tumor microenvironment.
    [Journal of Hematology & Oncology]

    Full Article

    Crosstalk between ILC2s and Th2 CD4+ T Cells in Lung Disease

    Scientists review the latest progress on type 2 innate lymphoid cells (ILC2s) and CD4+T cells in the lung, the close relationship between the two, and their relevance in the lung disease and immunity.
    [Journal of Immunology Research]

    Full Article

    INDUSTRY AND POLICY NEWS

    Surrozen Initiates Dosing in Phase I Clinical Trial of SZN-1326 for Moderate to Severe Ulcerative Colitis

    Surrozen, Inc. announced that the first subject has been dosed in its three-part Phase I clinical trial to evaluate SZN-1326 for the potential treatment of moderate to severe ulcerative colitis.
    [Surrozen, Inc.]

    Press Release

    Research Animals Mistreated by Leading Supplier, Animal Welfare Group Alleges

    The contract research organization Inotiv is neglecting animals at a research facility in Indiana that conducts toxicity testing of experimental drugs, the Humane Society of the United States alleged.
    [ScienceInsider]

    Press Release

    FEATURED EVENT

    Recent Insights Into Immuno-Oncology

    June 16 – 17, 2022
    Leuven, Belgium

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scholarship – Immunology

    Karolinska Institute – Stockholm, Sweden

    Postdoctoral Research Scientist – B Cell Immunology

    University of Oxford – Oxford, England, United Kingdom

    Research Technologist – Bioengineering

    STEMCELL Technologies, Inc. – Vancouver, British Columbia, Canada

    Postdoctoral Fellow – Stromal Immune Interactions in Cancer

    Cancer Research Center of Lyon – Lyon, France

    Tenure Track Faculty Position – Cell Signaling

    New York University College of Dentistry – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immune Regulation News Twitter